Control of Rubella Infection and Elimination of Congenital Rubella Syndrome by Surveillance and Vaccination
DOI:
https://doi.org/10.37591/rrjoi.v2i1.1162Abstract
Of the vaccine preventable child hood diseases, diphtheria, measles, tetanus, polio are controlled by effective vaccination program. The same is not true about rubella virus. Rubella virus is known to cause mild illness, but the virus when infects women in early pregnancy or just before conception can lead to the development of congenital rubella syndrome (CRS) in fetus or newborn. In America and European region, the CRS is virtually eliminated by effective surveillance and vaccination programs. Rubella infection and CRS cases are high in number in most of the countries of South East Asia region and Africa. In the absence of effective surveillance of rubella cases and vaccination against rubella, the CRS cases still persists. Since humans are the only reservoirs and availability of effective, safe vaccine, the elimination of CRS is attainable as achieved by the countries in the America region and European region due to routine surveillance and vaccination campaign. The control strategy should include massive vaccination of girls of child bearing age and also inclusion in the immunization schedule. Effective control of Measles by vaccination should be an eye opener to control rubella infection and therefore CRS in all other regions of the globe.
Keywords: Rubella virus infection, congenital rubella syndrome, vaccination, mental retardation, deafness, microcephaly.
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |
